PL2453901T3 - Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych - Google Patents

Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych

Info

Publication number
PL2453901T3
PL2453901T3 PL10734570T PL10734570T PL2453901T3 PL 2453901 T3 PL2453901 T3 PL 2453901T3 PL 10734570 T PL10734570 T PL 10734570T PL 10734570 T PL10734570 T PL 10734570T PL 2453901 T3 PL2453901 T3 PL 2453901T3
Authority
PL
Poland
Prior art keywords
fucosyllactose
treating
viral infections
breast milk
preventing viral
Prior art date
Application number
PL10734570T
Other languages
English (en)
Inventor
Bernd Stahl
Alma Jildou Nauta
Johan Garssen
Eric Samain
Sophie Drouillard
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41016877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2453901(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2453901T3 publication Critical patent/PL2453901T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL10734570T 2009-07-15 2010-07-12 Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych PL2453901T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09165485 2009-07-15
US25645309P 2009-10-30 2009-10-30
PCT/NL2010/050447 WO2011008087A1 (en) 2009-07-15 2010-07-12 Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
EP10734570.4A EP2453901B1 (en) 2009-07-15 2010-07-12 Fucosyllactose as breast milk identical non-digestible oligosaccharide for treating and/or preventing viral infections

Publications (1)

Publication Number Publication Date
PL2453901T3 true PL2453901T3 (pl) 2015-03-31

Family

ID=41016877

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10734570T PL2453901T3 (pl) 2009-07-15 2010-07-12 Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
PL17204679T PL3342413T3 (pl) 2009-07-15 2010-07-12 Fukozylolaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania biegunce wirusowej

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17204679T PL3342413T3 (pl) 2009-07-15 2010-07-12 Fukozylolaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania biegunce wirusowej

Country Status (9)

Country Link
US (5) US20120177691A1 (pl)
EP (4) EP4197542A1 (pl)
CN (1) CN102497869B (pl)
BR (1) BR112012000859B1 (pl)
ES (2) ES2525565T3 (pl)
MY (2) MY195771A (pl)
PL (2) PL2453901T3 (pl)
RU (1) RU2530641C2 (pl)
WO (1) WO2011008087A1 (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102497868A (zh) 2009-07-15 2012-06-13 N.V.努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
PL2453901T3 (pl) 2009-07-15 2015-03-31 Nutricia Nv Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
EP2465509A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
MY196432A (en) 2010-12-31 2023-04-10 Abbott Lab Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
CA2822219C (en) 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
BR112013016903A2 (pt) 2010-12-31 2019-09-24 Abbott Lab oligossacarídeos de leite humano para modular inflamação
DK2658399T4 (da) 2010-12-31 2024-03-25 Abbott Lab Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion
BR112013016606A2 (pt) 2010-12-31 2016-09-27 Abbott Lab processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
BR112013016587A2 (pt) 2010-12-31 2016-09-27 Abbott Lab formulações nutricionais incluindo oligossacarídeos de leite humano e antioxidantes e usos das mesmas
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
WO2012158517A1 (en) 2011-05-13 2012-11-22 Glycosyn LLC The use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
PH12014500185A1 (en) 2011-07-22 2019-10-11 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
HK1199607A1 (en) * 2011-08-29 2015-07-10 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MY168661A (en) * 2012-03-27 2018-11-28 Abbott Lab Methods for modulating cell-mediated immunity using human milk oligosaccharides
EP2656862A1 (en) 2012-04-24 2013-10-30 The Procter & Gamble Company Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
EP3111942B1 (en) * 2013-11-15 2021-01-06 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of urt infections in infants or young children at risk
WO2015071391A1 (en) * 2013-11-15 2015-05-21 Nestec S.A. Infant formulas containing a 2-fucosylated oligosaccharide for treatment or prevention of influenza infection
WO2015077233A1 (en) 2013-11-19 2015-05-28 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
HK1231398A1 (zh) * 2014-04-08 2017-12-22 Abbott Laboratories 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
CN107405354A (zh) * 2015-03-05 2017-11-28 格礼卡姆股份公司 治疗急性呼吸道感染的组合物和方法
CN107427054A (zh) 2015-03-05 2017-12-01 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿的耳炎或支气管炎的组合物
CN107404925A (zh) 2015-03-05 2017-11-28 雀巢产品技术援助有限公司 用于预防或治疗婴儿或幼儿胃肠感染/炎症的组合物
AU2016262843B2 (en) * 2015-05-19 2021-10-14 Société des Produits Nestlé S.A. Kit-of-parts to identify mother's milk missing fucosyltransferase-2 dependent glycans and feeding doses with said glycans
CN104940925A (zh) * 2015-07-17 2015-09-30 宁波荣安生物药业有限公司 一种人用狂犬病疫苗及其制备方法
US11179405B2 (en) * 2016-09-07 2021-11-23 Societe Des Produits Nestle S.A. Nutritional compositions for infants and/or young children comprising oligosaccharides
WO2019031961A1 (en) * 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
CN107373674A (zh) * 2017-08-25 2017-11-24 西宝生物科技（上海）股份有限公司 一种肿瘤治疗后的营养组合物及其应用
CN112423603A (zh) * 2018-07-12 2021-02-26 N·V·努特里奇亚 用于改善肠屏障完整性的营养组合物、组合物的制备以及治疗方法
AU2018431641B2 (en) * 2018-07-12 2024-11-28 N.V. Nutricia Nutritional composition for use in the treatment of diarrhea, its preparation and method of treatment
US20220226464A1 (en) * 2019-05-28 2022-07-21 Massachusetts Institute Of Technology Methods and compositions for modulating immune responses
US20220248739A1 (en) * 2019-05-29 2022-08-11 N.V. Nutricia Non-digestible oligosaccharides for decreased colonic protein fermentation
WO2020245313A1 (en) * 2019-06-04 2020-12-10 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and 3'galactosyllactose
EP4151097A1 (en) * 2019-06-04 2023-03-22 N.V. Nutricia Nutritional composition comprising 2'fucosyllactose and dietary butyrate
WO2021115578A1 (en) * 2019-12-10 2021-06-17 N.V. Nutricia Purified non-dairy vegetable protein
CN111011864A (zh) * 2019-12-27 2020-04-17 内蒙古蒙牛乳业（集团）股份有限公司 一种促进肠道健康的营养组分
EP3888661B1 (en) * 2020-03-31 2025-12-17 FrieslandCampina Nederland B.V. Compositions comprising 2 -fucosyllactose to prevent viral infections
KR102435547B1 (ko) * 2020-12-11 2022-08-24 (주)에이피테크놀로지 푸코실락토스를 유효성분으로 함유하는 항바이러스 조성물
CN117919262A (zh) * 2022-12-12 2024-04-26 天津市肿瘤医院（天津医科大学肿瘤医院） 2′-岩藻糖基乳糖作为一种抗肿瘤辅助药物与抗pd-1药物联合用于制备治疗结肠癌药物的用途
US12527342B2 (en) * 2024-01-12 2026-01-20 Nutifood Nutrition Food Joint Stock Company Supplementary composition containing 2′-fucosyllactose (2′-fl) and fructo-oligosaccharide (FOS) with synergistic effects on the digestive and immune systems for children, and process of manufacturing a children formula containing said supplementary composition

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002759A (en) * 1989-07-25 1991-03-26 Colgate-Palmolive Company Oligosaccharide inhibition of Streptococcus pyogenes adhesion
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US20020019991A1 (en) * 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
HUP0204546A3 (en) 2000-03-01 2003-10-28 Nestle Sa Carbohydrate formulation for enhancement of immune response
FR2814471B1 (fr) * 2000-09-27 2004-12-17 Centre Nat Rech Scient Utilisation de polymeres et d'oligomeres de xyloglucane, et de composes derives, en tant que produits phytosanitaires et biofertilisants
SG152271A1 (en) * 2003-10-24 2009-05-29 Nutricia Nv Immunemodulating oligosaccharides
PL1675481T3 (pl) 2003-10-24 2009-03-31 Nutricia Nv Kompozycja synbiotyczna dla niemowląt
WO2005055944A2 (en) * 2003-12-05 2005-06-23 Cincinnati Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
BRPI0607633A2 (pt) * 2005-02-21 2009-09-22 Nestec Sa mistura de oligossacarìdeo
WO2007010084A2 (en) 2005-07-15 2007-01-25 Johannes Savolainen Immunostimulatory oligo- and polysaccharides and uses thereof
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007067033A1 (en) 2005-12-06 2007-06-14 N.V. Nutricia Composition containing oligosaccharides for the treatment/ prevention of infections
CA2645472C (en) * 2006-03-10 2015-09-15 N.V. Nutricia Use of non-digestable saccharides for giving an infant the best start after birth
WO2007114683A1 (en) 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
US9239329B2 (en) * 2006-12-18 2016-01-19 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
WO2009067000A1 (en) 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
PL2453901T3 (pl) 2009-07-15 2015-03-31 Nutricia Nv Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
CN102497868A (zh) * 2009-07-15 2012-06-13 N.V.努特里奇亚 用于刺激免疫系统的不可消化低聚糖的混合物
MY196432A (en) 2010-12-31 2023-04-10 Abbott Lab Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
WO2015071391A1 (en) 2013-11-15 2015-05-21 Nestec S.A. Infant formulas containing a 2-fucosylated oligosaccharide for treatment or prevention of influenza infection
EP3079501B1 (en) 2013-12-12 2019-08-14 Société des Produits Nestlé S.A. Synthetic nutritional compositions especially adapted for male and female infants and young children

Also Published As

Publication number Publication date
EP3342413B1 (en) 2021-10-20
ES2525565T3 (es) 2014-12-26
EP4197542A1 (en) 2023-06-21
BR112012000859A2 (pt) 2018-03-13
RU2012105310A (ru) 2013-08-20
EP2453901A1 (en) 2012-05-23
RU2530641C2 (ru) 2014-10-10
PL3342413T3 (pl) 2022-03-28
EP2453901B1 (en) 2014-09-10
EP3342413A1 (en) 2018-07-04
EP2813230A1 (en) 2014-12-17
US20180264104A1 (en) 2018-09-20
US20120177691A1 (en) 2012-07-12
MY195771A (en) 2023-02-10
US10588965B2 (en) 2020-03-17
MY164674A (en) 2018-01-30
US11135290B2 (en) 2021-10-05
WO2011008087A1 (en) 2011-01-20
BR112012000859B1 (pt) 2021-08-03
US20220023418A1 (en) 2022-01-27
US20160158346A1 (en) 2016-06-09
CN102497869B (zh) 2013-11-27
CN102497869A (zh) 2012-06-13
ES2904608T3 (es) 2022-04-05
US20200155672A1 (en) 2020-05-21

Similar Documents

Publication Publication Date Title
PL2453901T3 (pl) Fukozyloklaktoza jako identyczny z mlekiem kobiecym niestrawny oligosacharyd do leczenia i/lub zapobiegania infekcji wirusowych
PH12013500952A1 (en) Oligosaccharide composition for treating acute respiratory tract infections
GB2471806B (en) Compositions and methods for treating viral infections
EP2440251A4 (en) INTERFERON ADMINISTRATION FOR PROPHYLAXIS AGAINST PATHOGEN INFECTION OR TREATMENT OF PATHOGEN INFECTION
SG10201507032YA (en) Benzoxaborole derivatives for treating bacterial infections
WO2011056650A9 (en) Methods and compositions for treating and preventing viral infections
IL253038A0 (en) Preparations and methods for the treatment or prevention of infections. my voice
SI2627334T1 (sl) Sestavki za uporabo pri zdravljenju virusnih infekcij
EP2480255A4 (en) THERAPY FOR ENTERIC INFECTIONS
AP2011005901A0 (en) Thienopyridine derivatives for the treatment and prevention of dengue virus infections.
ZA201005737B (en) Methods of treating viral infections
EP2356236A4 (en) SIRNA COMPOSITIONS AND METHODS FOR HIGHLY INHIBITING VIRAL INFECTION
DK2473482T3 (en) Methods of treating orthomyxoviral infections
PT2424559T (pt) Métodos de tratamento de infeções bacterianas utilizando oritavancina
IL218286A0 (en) Targeting pax2 for the treatment of breast canecr
EP2624841A4 (en) COMPOSITIONS FOR TREATING CHRONIC VIRAL INFECTIONS
EP2410846A4 (en) GLYCOLIPIDES AS TREATMENT OF DISEASES
PT2725930E (pt) Soluções para esterilização e pasteurização sem molibdatos
ZA201204249B (en) Treatment of microbial infections
ZA201306342B (en) The treatment of viral infections
PH12012500528A1 (en) Compositions and methods for treating bacterial infections using caftaroline
PT2647369T (pt) Pacap para o tratamento de infeções virais em organismos aquáticos
EP2704730A4 (en) TREATMENT OF MICROBIAL INFECTIONS WITH BIRD EXTRACTS
GB201012168D0 (en) Treatment of viral infections
GB0913914D0 (en) Treatment of viral infections